ARTICLE | Clinical News
Vonapanitase: Ph III PATENCY-1 data
December 16, 2016 8:24 PM UTC
Top-line data from the double-blind, U.S. Phase III PATENCY-1 trial in 313 CKD patients receiving or expecting hemodialysis who underwent surgical creation of a radiocephalic AVF showed that a single ...
BCIQ Company Profiles
BCIQ Target Profiles